Anaqua, Inc., a leading provider of intellectual property management software and services, today announced that Ceva Santé Animale, one of the world’s fastest growing animal healthcare companies, has entered into a multi-year agreement to use the ANAQUA IP platform to manage its global portfolio of patents, inventions, trademarks, and awards.
Headquartered in France, Ceva has 12 research and development centers, 25 production sites and more than 5,000 employees across more than 100 countries worldwide. With a sizeable and growing portfolio of patents, trademarks and inventions, Ceva was seeking to upgrade its IP management systems and bring all of its IP assets onto a single platform, thereby increasing efficiency, saving time and reducing costs.
“With Anaqua’s unified IP management software, Ceva will be able to better manage the innovation process and more easily track the status of their valuable IP assets worldwide,” said Bob Romeo, CEO of Anaqua. “Ceva has a truly global network of R&D teams who work together to keep shifting the boundaries of science, and we are looking forward to supporting their IP and innovation.”
Anaqua’s software will manage all of Ceva’s IP assets through a sole system across the entire company. It will substantially automate and streamline daily docketing operations and provide flexible, reliable and updated reporting tools for its IP decisions.
ABOUT ANAQUA
The most innovative companies in the world
innovate with Anaqua. Its simplified software platform combines insight
from big data analytics with critical tools, best practice workflows and
advanced services. Today, the Anaqua software manages nearly 25% of the
world’s IP. Many of the best-known brands and most innovative products
were conceptualized, evaluated, protected and monetized through the
ANAQUA platform. Founded in 2004 by IP leaders from The Coca-Cola
Company, Ford Motor Company and British American Tobacco, Anaqua is a
privately held company headquartered in Boston (U.S.) with offices
across Europe and Asia. For additional information, please visit www.anaqua.com.
ABOUT CEVA
Ceva Santé Animale is a global veterinary
healthcare company, focused on research, development, production and
marketing of pharmaceutical products and vaccines for companion animals,
livestock, swine and poultry. Founded in 1999 and headquartered in
Libourne, France, Ceva has a presence in 110 countries. With a proven
record of double-digit growth, Ceva is the world’s fastest growing top
10 animal healthcare companies. Ceva Chairman and CEO is Marc Prikazsky.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180214005036/en/
Contacts:
Tony
Catinella, 617-375-2626
Public Relations Manager
acatinella@Anaqua.com